Delivery Order SPE2DB24D8001-SPE2DB24FKZCF
Award Date
9/24/24
Potential Completion Date
9/25/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $13,879.12 firm fixed-price delivery order is for the supply of 100 units of CONCERTA ER 18 MG TABLET, a prescription medication. The contract has an ultimate completion date of March 11, 2025. Dakota Drug, Inc. is an established federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTRD, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4566999336 CONCERTA ER 18 MG TABLET 100S and has a firm fixed price ceiling value of $5,948.93. The award was made on January 21, 2025, with a performance period extending through January 22, 2025. Dakota Drug, Inc. holds a significant single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $5,924.06 firm fixed-price delivery order is for the supply of 4565891400 CONCERTA ER 18 MG TABLET 100S. The contract, which does not have a set-aside designation, has an ultimate completion date of September 23, 2024. Dakota Drug, Inc. also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $10,797.75, is a firm fixed-price delivery order without a set-aside designation. It covers the supply of 4,564,879,318 units of CONCERTA ER 36 MG TABLET 100S, a prescription medication, to support the medical supply chain operations for the U.S. Armed...
This federal contract award, valued at $5,353.16, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order (SPE2DB25FJTSA) under the larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows Dakota Drug, Inc. to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This federal contract award to Dakota Drug, Inc. is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $12,427.91. The contract is for the delivery of Concerta ER 27 mg tablets, and is structured as a firm fixed-price agreement without any set-aside designation. Dakota Drug, Inc. is the prime contractor for this award, and is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The company...
This federal contract award, valued at $5,702.38, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of CONCERTA ER 27 MG TABLET 100S, a prescription medication. This award is a delivery order under the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that allows Dakota...
This federal contract award, valued at $4,524.18, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for the supply of 4565631842 CONCERTA ER 36 MG TABLET 100S, a prescription medication. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC allows the company to provide a comprehensive range of...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBPXC, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,740.41, is for the delivery of 100 units of the pharmaceutical product CONCERTA ER 36 MG TABLET. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 17, 2023. Dakota Drug, Inc. is a critical vendor for the DLA's medical supply chain...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,172.38 firm fixed price delivery order is for the supply of CONCERTA ER 36 MG TABLET 100S. The contract has a performance period through November 19, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which allows the company to...